RxSight, Inc. (RXST)
4.88
+0.05
(+1.04%)
USD |
NASDAQ |
Nov 18, 10:54
RxSight Enterprise Value : -41.85M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | -41.85M |
| November 16, 2026 | -22.15M |
| November 13, 2026 | -21.31M |
| November 12, 2026 | -18.79M |
| November 11, 2026 | -22.99M |
| November 10, 2026 | -38.92M |
| November 09, 2026 | -40.60M |
| November 06, 2026 | -54.01M |
| November 05, 2026 | -54.01M |
| November 04, 2026 | -35.15M |
| November 03, 2026 | -51.92M |
| November 02, 2026 | -43.11M |
| October 30, 2026 | -40.18M |
| October 29, 2026 | -32.63M |
| October 28, 2026 | -38.92M |
| October 27, 2026 | -38.92M |
| October 26, 2026 | -37.66M |
| October 23, 2026 | -33.89M |
| October 22, 2026 | -31.37M |
| October 21, 2026 | -38.92M |
| October 20, 2026 | -39.76M |
| October 19, 2026 | -47.72M |
| October 16, 2026 | -55.27M |
| October 15, 2026 | -48.56M |
| October 14, 2026 | -54.85M |
| Date | Value |
|---|---|
| October 13, 2026 | -54.43M |
| October 12, 2026 | -48.98M |
| October 09, 2026 | -42.69M |
| October 08, 2026 | -41.02M |
| October 07, 2026 | -43.11M |
| October 06, 2026 | -49.40M |
| October 05, 2026 | -44.79M |
| October 02, 2026 | -48.14M |
| October 01, 2026 | -45.21M |
| September 30, 2026 | -38.92M |
| September 29, 2026 | 0.1434M |
| September 28, 2026 | -4.015M |
| September 25, 2026 | -4.431M |
| September 24, 2026 | -1.520M |
| September 23, 2026 | 3.470M |
| September 22, 2026 | 6.797M |
| September 21, 2026 | 15.53M |
| September 18, 2026 | 18.03M |
| September 17, 2026 | 23.02M |
| September 16, 2026 | 26.34M |
| September 15, 2026 | 35.49M |
| September 14, 2026 | 55.66M |
| September 11, 2026 | 52.13M |
| September 10, 2026 | 49.63M |
| September 09, 2026 | 65.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Precision Optics Corp., Inc. | 40.71M |
| Globus Medical, Inc. | 8.876B |
| Abbott Laboratories | 208.81B |
| Align Technology, Inc. | 10.56B |
| AngioDynamics, Inc. | 464.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.22M |
| Revenue (Quarterly) | 24.59M |
| Total Expenses (Quarterly) | 40.81M |
| EPS Diluted (Quarterly) | -0.389 |
| Gross Profit Margin (Quarterly) | 73.62% |
| Profit Margin (Quarterly) | -65.99% |
| Earnings Yield | -26.38% |
| Normalized Earnings Yield | -26.38 |